… by the FDA for pulmonary sarcoidosis since glucocorticoids and repository … ever interventional trial in pulmonary sarcoidosis. Presented at: European Respiratory … Boehringer Ingelheim, the Foundation for Sarcoidosis Research, Molecure and NIH; honoraria …

… : Revealing pathogenic signatures in sarcoidosis using single-cell genomics • … )regulation of phagosomal dynamics in sarcoidosis pathogenesis •  Institution: Yale … : Elucidating the metabolic characteristics of sarcoidosis  •  Institution: Medical University …

… powerful cross-section of the sarcoidosis community, including patients, caregivers, … collaboration, and advocacy for the sarcoidosis community,” said Mary McGowan, President … to contact FSR directly. About Sarcoidosis Sarcoidosis (pronounced SAR-COY-DOE-SIS …

… examined psychiatric manifestations in sarcoidosis patients. The meta-analysis … psychiatric assessment tools in routine sarcoidosis management. Early identification and … of psychiatric complications in sarcoidosis. Addressing these challenges through …

… study of patients with cutaneous sarcoidosis, ECG abnormalities identified all cases … .6%. All patients with cardiac sarcoidosis had other extracutaneous manifestations. IN … and small number of cardiac sarcoidosis cases. Additionally, variations in detection …

… patient quality of life. About Sarcoidosis Sarcoidosis is a rare inflammatory disease … . Despite advances in research, sarcoidosis remains challenging to diagnose, with … the Foundation for Sarcoidosis Research The Foundation for Sarcoidosis Research (FSR) …

… forward for efzofitimod in pulmonary sarcoidosis. Dr Sanjay S. Shukla, president … that patients with chronic, symptomatic sarcoidosis can be managed with substantially … enrolled 268 patients with pulmonary sarcoidosis, evaluating the efficacy and safety …

… improvement in the King’s Sarcoidosis Questionnaire (KSQ)-Lung score … of quality of life in sarcoidosis. Additionally, a responder analysis … the next steps.” Pulmonary sarcoidosis is a serious form … largest interventional trial in sarcoidosis to date. He noted …

… weeks in people with pulmonary sarcoidosis although clinical benefits were … largest interventional study completed in sarcoidosis to date, demonstrating the feasibility … that patients with chronic, symptomatic sarcoidosis can be managed with substantially …

… largest interventional study completed in sarcoidosis to date, demonstrating the … the event. About Pulmonary Sarcoidosis Pulmonary sarcoidosis is an inflammatory disease … development of efzofitimod in pulmonary sarcoidosis; and certain development goals. …